retatrutide and type 1 diabetes Medscape | The investigational triple GLP-1/GIP/glucagon receptor agonist produced significant weight loss A1c reduction in people Efficacy and Safety of Retatrutide

Increased mitochondrial mass and cytosolic redox imbalance in hippocampal astrocytes of a mouse model of rett syndrome: subcellular changes revealed by ratiometric imaging of JC-1 and roGFP1 fluorescence

As an athlete and as someone that has done everything, I just couldnt get my weight to where I needed to be at a healthy place, and believe me, I dont take shortcuts, she said

Then they found the secondary benefit of reducing their alcohol use, and their liver disease is starting to heal. The stimulant addiction study is a two-phase pilot that began in January with an initial 25 participants

GLP-1s & the Future of Digital Health Social Sharing 01.30.2025 This discussion delves into the current and future landscape of GLP-1 receptor agonists, particularly their market size, adoption drivers, pricing dynamics, regulatory challenges, and broader societal impacts